Spikevax 2025-26 (6M-11Y) SYR 0.25ML
Ended Awarded Last action
- Contract number
- SPE2DR26FP7RZ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,261
Award facts
- Contract value 100% obligated
- $1,261.08 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for SPIKEVAX 2025-26 (6M-11Y) syringes at a ceiling value of $1,261.08 under a firm fixed-price contract. The delivery order, which became effective on December 2, 2025, with an ultimate completion date of December 23, 2025, is for pediatric COVID-19 vaccine doses in single 0.25 mL syringes. This award represents a non-competitive delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at approximately $1 billion through December 2026. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company's prime IDC with DLA enables comprehensive global pharmaceutical support across multiple therapeutic domains, including vaccines, specialty medications, and medical supplies. This delivery order for pediatric COVID-19 vaccines supports the Defense Health Agency and other federal healthcare systems requiring immunization supplies for military-connected populations. The non-set-aside contract award reflects AmerisourceBergen's demonstrated capability to meet federal procurement requirements and its established role as a preferred pharmaceutical supplier to the Department of Defense.
Quick answers
Who was awarded contract SPE2DR26FP7RZ?
SPE2DR26FP7RZ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 2, 2025.
How much is contract SPE2DR26FP7RZ worth?
The government has obligated $1,261 on SPE2DR26FP7RZ.
Is contract SPE2DR26FP7RZ an order under another contract?
Yes. SPE2DR26FP7RZ is a delivery order under SPE2DR25D3005, an indefinite delivery contract.
Was contract SPE2DR26FP7RZ competed?
The extent of competition for SPE2DR26FP7RZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award